CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Magnus Transcranial Magnetic Neuromodulation System (MNS) with SAINT®(Stanford Accelerated Intelligent Neuromodulation Therapy)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05375214
NCT05375214N/ACompleted
CompareCT.gov

A Pilot Study of iTBS in Bipolar I Depression

Johns Hopkins University·interventional·Posted May 16, 2022·Updated Aug 1, 2024

In Brief

A clinical study evaluating Magnus Transcranial Magnetic Neuromodulation System (MNS) with SAINT®(Stanford Accelerated Intelligent Neuromodulation Therapy) for Bipolar Depression and Bipolar I Disorder. Completed, enrolled 10 participants across 2 sites.

Detailed Summary

A multisite, open label pilot study to investigate the efficacy and safety of a novel accelerated intermittent theta-burst stimulation (iTBS) protocol while assessing for changes in neuroimaging biomarkers associated with treatment response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Depression, Bipolar I Disorder
CountriesUnited States
CollaboratorsBaszucki Brain Research Fund, Magnus Medical, University of Texas at Austin

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 16, 2022
Enrollment StartMar 3, 2023
Primary CompletionOct 31, 2023
Study CompletionNov 22, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.1 years ago

Interventions

Magnus Transcranial Magnetic Neuromodulation System (MNS) with SAINT®(Stanford Accelerated Intelligent Neuromodulation Therapy)device

Novel intermittent theta burst stimulation protocol with individualized targets in the brain for stimulation using structural and functional MRI inputs